Contact
Please use this form to send email to PR contact of this press release:
Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults
TO:
Paul Rolan
GPN Vaccines
+61 405 670 420